Sponsor delays: Green light to start the study not given Phase 3, Multi-Centre, Double-Blind, Randomised, 14/SC/0032 19/06/2014 No NO until 18/12/2014. Eligibility Parallel Group Evaluation of the Efficacy, Safety criteria prohibitive requiring and Tolerability of PF-04950615, in reducing the occurrence of very specific disease criteria. major cardiovascular events in high risk subjects. SPIRE 1. A Phase 2 Study for Older Adults with Acute Lymphoblastic 12/LO/1319 11/06/2014 No NO Small patient population Leukaemia UKALL 60+ Pilot study: Finger prick fresh blood for treatment of chronic 14/EE/0032 03/06/2014 08/08/2014 YES corneal ulcers, persistent epithelial defects and dry eyes. TARDIS - Safety and efficacy of intensive versus guideline Study closed at site due to antiplatelet therapy in high risk patients with recent ischaemic 08/H1102/112 12/05/2014 No NO lack of suitable patients stroke or transient ischaemic attack: a randomised controlled presenting trial Ocriplasmin for Vitreomacular Traction/Symptomatic 14/SC/0100 09/05/2014 14/05/2014 YES Vitreomacular Adhesion A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a 13/LO/1320 07/04/2014 19/05/2014 YES Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye (pSivida)
14/SC/0032 Phase 3, Multi-Centre, Double-Blind, Randomised, Parallel Group Evaluation of the Efficacy, Safety and Tolerability of PF-04950615, in reducing the occurrence of major cardiovascular events in high risk subjects. SPIRE 1. 19/06/2014 No NO Sponsor delays: Green light to start the study not given until 18/12/2014. Eligibility criteria prohibitive requiring very specific disease criteria. 12/LO/1319 A Phase 2 Study for Older Adults with Acute Lymphoblastic Leukaemia UKALL 60+ 11/06/2014 No NO Small patient population 14/EE/0032 Pilot study: Finger prick fresh blood for treatment of chronic corneal ulcers, persistent epithelial defects and dry eyes. 03/06/2014 08/08/2014 YES 08/H1102/112 TARDIS - Safety and efficacy of intensive versus guideline antiplatelet therapy in high risk patients with recent ischaemic stroke or transient ischaemic attack: a randomised controlled trial 12/05/2014 No NO Study closed at site due to lack of suitable patients presenting 14/SC/0100 Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion 09/05/2014 14/05/2014 YES 13/LO/1320 A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye (pSivida) 07/04/2014 19/05/2014 YES